This is a routine ESOP exercise with no trading implications. Monitor next quarterly filing for any changes in share count or material business developments.
RDY drugs
RDY drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Sep 10 $11.71entry
- T+1 · 2mo ago +1.62%α +0.77% · $11.90
- T+5 · due 2mo ago Pending
- T+20 · due 6w ago Pending
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Reddy's filed a routine 6-K reporting the allotment of 375 equity shares upon exercise of stock options under its ADR Stock Option Scheme. This is a de minimis issuance representing approximately 0.00004% of total outstanding shares, with no material financial impact or strategic significance.
Key Facts
- Allotted 375 equity shares of Re. 1 each on September 10, 2026
- Issued under Dr. Reddy's Employees ADR Stock Option Scheme, 2007
- Exercise price was Re. 1 per share
- Total issued shares after allotment: 83,46,81,285
- Dilution is negligible at ~0.00004% of outstanding shares
Financial Impact
Negligible, 375 shares at Re. 1 par value, no premium. Total dilution is approximately 0.00004% of outstanding shares.
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (RDY), Batch item 1 | 0001575872-26-000642 |
| Document: 0001575872-26-000642-index.html | 0001575872-26-000642 |
| Document: 0001575872-26-000642.txt | 0001575872-26-000642 |
| 6-K Filing (RDY), Batch item 4 | 0001575872-26-000642 |
| Document: 0001575872-26-000642-index.html | 0001575872-26-000642 |
| Document: 0001575872-26-000642.txt | 0001575872-26-000642 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers